About Us

Expression Therapeutics is a biotechnology company based in Atlanta. Our therapeutic pipeline includes advanced gene therapies for hemophilia A and B; neuroblastoma, T-cell leukemia/lymphoma, and acute myeloid leukemia (AML); and hematologic disorders such as hemophagocytic lymphohistiocytosis (HLH). Each product candidate has been specifically engineered using proprietary gene expression biotechnologies designed for optimal safety and efficacy.


Our Mission

Our mission is to develop novel gene therapies that will dramatically improve the lives of patients.